Status:

RECRUITING

Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.

Lead Sponsor:

Jasper A. Smits

Collaborating Sponsors:

University of Houston

University of Oklahoma

Conditions:

Nicotine Dependence

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation inte...

Detailed Description

This protocol provides the recommended treatment to achieve smoking cessation (i.e., counseling and nicotine replacement therapy) and randomly assigns individuals to a high-intensity exercise or low-i...

Eligibility Criteria

Inclusion

  • Adult (age ≥ 18);
  • High Anxiety Sensitivity (≥5 on the Short Scale Anxiety Sensitivity Index \[SSASI\]);
  • Daily smoker, ≥5 cigarettes (including e-cigarettes, little cigars/cigarillos) for ≥1 year;
  • Motivated to quit smoking as evidenced by a score of ≥5 on a 0-10 Likert scale;
  • Body mass index \<40;
  • Medical clearance to participate.
  • Located near a participating YMCA site (within 50 miles)

Exclusion

  • Regular exercise defined as engaging in vigorous-intensity exercise for at least 75 minutes per week for the last 3 months
  • Receiving current intervention for smoking cessation.
  • Outstanding debt to the YMCA
  • Listed as a sex offender on the National Sex Offender Registry

Key Trial Info

Start Date :

December 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2028

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT06053567

Start Date

December 27 2023

End Date

June 30 2028

Last Update

April 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas at Austin

Austin, Texas, United States, 78712